Review on lipegfilgrastim

• Main Authors: Gasparic M, Leyman S
• Format: Article
• Language: English
• Published: Dove Medical Press 2015-11-01
• Series: International Journal of Nanomedicine
• Online Access: https://www.dovepress.com/review-on-lipegfilgrastim-peer-reviewed-article-IJN

Maja Gasparic, Sophie LeymanTeva Pharmaceuticals Europe BV, European Headquarters, Amsterdam, the NetherlandsHaving read the original Hoggatt et al article1 and the corrigendum published online on August 27, 2015,2 we do not consider the description of lipegfilgrastim to be entirely accurate, and we would therefore like to clarify what lipegfilgrastim actually is.The description of lipegfilgrastim used in the original article was a “long-acting biosimilar filgrastim”.1 This description was subsequently amended in the corrigendum to “lipegfilgrastim has an active substance that is similar to filgrastim, with similar pharmacokinetics, receptor binding affinity, safety and efficacy as pegfilgrastim”.2  Read the Corrigendum